CEO
BioLattice Ophthalmics
Philadelphia, Pennsylvania, United States
Disclosure information not submitted.
Functionalizing Solvent-Cast Chitosan/Polycaprolactone Membranes for Artificial Corneal Replacement
Friday, October 25, 2024
2:30 PM – 2:45 PM EST